Know Labs, Inc.
About: Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.
Employees: 6
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
2.12% less ownership
Funds ownership: 3.34% [Q4 2024] → 1.22% (-2.12%) [Q1 2025]
70% less funds holding
Funds holding: 30 [Q4 2024] → 9 (-21) [Q1 2025]
96% less capital invested
Capital invested by funds: $616K [Q4 2024] → $23.6K (-$592K) [Q1 2025]
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 21
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 9
Research analyst outlook
We haven’t received any recent analyst ratings for KNW.
Financial journalist opinion
Based on 6 articles about KNW published over the past 30 days
Neutral
PRNewsWire
3 days ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW, ELEV, CRKN on Behalf of Shareholders
NEW YORK , June 12, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Know Labs, Inc. (NYSE American: KNW)'s sale to Goldeneye 1995 LLC. If you are a Know Labs shareholder, click here to learn more about your legal rights and options.
Neutral
Business Wire
5 days ago
KNOW LABS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Know Labs, Inc. - KNW
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Know Labs, Inc. (NYSE: KNW) to Goldeneye 1995 LLC (“Buyer”). Under the terms of the proposed transaction, the Buyer will acquire that number of shares of the Company's common stock obtained by dividing (i) the sum of 1,000 Bitcoin and a cash sum to retire existing debt, redeem outstanding preferred.
Neutral
GlobeNewsWire
6 days ago
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Know Labs, Inc. (NYSE: KNW)
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Know Labs, Inc. (NYSE: KNW ) related to its sale to Goldeneye 1995 LLC. Under the terms of the agreement, the Buyer will acquire that number of shares of the Company's common stock obtained by dividing (i) the sum of 1,000 Bitcoin and a cash sum to retire existing debt, redeem outstanding preferred equity and provide additional working capital, by (ii) the per share purchase price of $0.335.
Positive
Finbold
1 week ago
This stock rallies over 200% on Bitcoin-led buyout of parent company
Know Labs (NYSE: KNW), a little-known healthcare stock, has skyrocketed over 200% following an interesting acquisition of its parent company, mainly funded through Bitcoin (BTC).
Neutral
Business Wire
1 week ago
KNW Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Know Labs, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Know Labs, Inc. (NYSE American: KNW) to Goldeneye 1995 LLC is fair to Know Labs shareholders. Halper Sadeh encourages Know Labs shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Know Labs and its board of directo.
Neutral
Business Wire
1 week ago
Greg Kidd to Acquire Controlling Interest in Know Labs and Introduce Bitcoin Treasury Strategy
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW (“Know Labs” or the “Company”), a technology innovator specializing in non-invasive health monitoring solutions, today announced that it has entered into an agreement with Goldeneye 1995 LLC (“Buyer”), an affiliate of fintech investor, entrepreneur, and former Ripple Chief Risk Officer, Greg Kidd, to acquire a controlling interest in the Company. Upon the closing of the transaction, Mr. Kidd will become Chief Executive Officer and Ch.
Neutral
Business Wire
2 months ago
Know Labs Sensor Non-Invasively Identifies pH Levels in Real Time
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) is pleased to announce that it has completed extensive research in its laboratory utilizing its patented Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology to identify changes in pH levels in real time. The research has been submitted for peer reviewed publication. The research is available for review today here on the Company's website at www.knowlabs.co. An abstract of the paper states, “We describe an experiment in.
Neutral
Business Wire
2 months ago
Know Labs to Attend the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology with its Radio Frequency Dialectic Spectroscopy (RFDS) platform, today announced the company will be attending The 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) Technology Fair in Amsterdam, Netherlands on March 19-22, 2025. The Company will share updates on the development of its non-invasive blood glucose monitor, sin.
Neutral
Business Wire
3 months ago
Know Labs Announces Cancellation of Special Meeting of Stockholders
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (previously NYSE American: KNW, now OTC Pink Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today the cancellation of the Special Meeting of Stockholders previously scheduled for March 7, 2025 (Special Meeting), which was intended to seek approval for a reverse stock split. The Company's decision to cancel the Special Meeting comes after the Company announced a 1 for 40.
Neutral
Business Wire
3 months ago
Know Labs Announces Reverse Stock Split Effective February 19, 2025
SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (previously NYSE American: KNW, now OTC Pink Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today a 1 for 40 reverse stock split of its authorized and issued and outstanding shares of common stock. The reverse stock split was announced on February 18, 2025. The reverse stock split will be effective as of the morning of February 19, 2025, and the Company's common stock w.
Charts implemented using Lightweight Charts™